<H1>Chapter DOI: 10.1007/978-1-60327-931-4_16<br/>Cited-By Count: 16</H1><table border="1" width="30%"><tr><td>Total References</td><td>24</td></tr><tr><td>Springer references</td><td>1</td></tr><tr><td>Non Springer references</td><td>23</td></tr><tr><td>BibStructured Count</td><td width="10%">22</td></tr><tr><td>BibUnstructured Count</td><td width="10%">2</td></tr><tr><td>DOI already available in SpringerLink</td><td>14</td></tr><tr><td>Additional DOI extracted from CrossRef-Meta</td><td>2</td></tr><tr><td>Additional DOI extracted from CrossRef-Web</td><td>0</td></tr><tr><td>Additional DOI extracted from ResearchGate-Web</td><td>0</td></tr><tr><td>Additional DOI extracted from SpringerLink-FUZZY-Search</td><td>0</td></tr><tr><td>Spelling Mistakes</td><td>NULL</td></tr><tr><td>Wrong DOI</td><td>0</td></tr><tr><td>ISBN</td><td>NULL</td></tr><tr><td>Web Link</td><td>NULL</td></tr><tr><td>DOI Obtained For Springer Published</td><td>0</td></tr><tr><td>DOI Obtained For Non Springer</td><td>2</td></tr><tr><td>DOI Obtained From Structured Ref</td><td>2</td></tr><tr><td>DOI Obtained From Unstructured Ref</td><td>0</td></tr><tr><td>Valid DOI Enriched</td><td>1</td></tr></table></br></br><table border="1">
<tr><th>Bib. ID</th><th>Ref. Type</th><th>References</th><th>DOI</th><th>Suspected DOI</th><th>DOI Source</th><th>Validated Elements</th><th>Validation Source</th></tr><tr><td>CR1_16</td><td>BibArticle</td><td>Burt RK, Burns W, Ruvolo P, et al. (1995). Syngeneic bone marrow transplantation eliminates V beta 8.2 T lymphocytes from the spinal cord of Lewis rats with experimental allergic encephalomyelitis. J Neurosci Res; 41:526&#8211;531.</td><td><a href=http://dx.doi.org/10.1002/jnr.490410412>10.1002/jnr.490410412</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR2_16</td><td>BibArticle</td><td>van Gelder M, Kinwel-Bohre EP, van Bekkum DW. (1993). Treatment of experimental allergic encephalomyelitis in rats with total body irradiation and syngeneic BMT. Bone Marrow Transplant; 11:233&#8211;241.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR3_16</td><td>BibArticle</td><td>Fassas A, Anagnostopoulos A, Kazis A, et al. (1997). Peripheral blood stem cell transplantation in the treatment of progressive multiple sclerosis: first results of a pilot study. Bone Marrow Transplant; 20:631&#8211;638.</td><td><a href=http://dx.doi.org/10.1038/sj.bmt.1700944>10.1038/sj.bmt.1700944</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR4_16</td><td>BibArticle</td><td>Atkins H and Freedman M. (2005). Immunoablative therapy as a treatment aggressive multiple sclerosis. Neurol Clin; 23:273&#8211;300, ix.</td><td><a href=http://dx.doi.org/10.1016/j.ncl.2004.09.004>10.1016/j.ncl.2004.09.004</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR5_16</td><td>BibArticle</td><td>Freedman MS and Atkins HL. (2004). Suppressing immunity in advancing MS: too much too late, or too late for much? Neurology; 62:168&#8211;169.</td><td><a href=http://dx.doi.org/10.1212/WNL.62.2.168>10.1212/WNL.62.2.168</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR6_16</td><td>BibArticle</td><td>Gratwohl A, Passweg J, Bocelli-Tyndall C, et al. (2005). Autologous hematopoietic stem cell transplantation for autoimmune diseases. Bone Marrow Transplant; 35:869&#8211;879.</td><td><a href=http://dx.doi.org/10.1038/sj.bmt.1704892>10.1038/sj.bmt.1704892</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR7_16</td><td>BibUnstructured</td><td>Personal Communication.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR8_16</td><td>BibArticle</td><td>Nash RA, Bowen JD, McSweeney PA, Pavletic SZ, Maravilla KR, Park MS, Storek J, Sullivan KM, Al-Omaishi J, Corboy JR, DiPersio J, Georges GE, Gooley TA, Holmberg LA, LeMaistre CF, Ryan K, Openshaw H, Sunderhaus J, Storb R, Zunt J, Kraft GH. (2003). High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis. Blood; 102(7):2364&#8211;2372.</td><td><a href=http://dx.doi.org/10.1182/blood-2002-12-3908>10.1182/blood-2002-12-3908</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR9_16</td><td>BibArticle</td><td>Burt RK, Cohen BA, Russell E, Spero K, Joshi A, Oyama Y, Karpus WJ, Luo K, Jovanovic B, Traynor A, Karlin K, Stefoski D, Burns WH. (2003). Hematopoietic stem cell transplantation for progressive multiple sclerosis: failure of a total body irradiation-based conditioning regimen to prevent disease progression in patients with high disability scores. Blood; 102(7):2373&#8211;2378.</td><td><a href=http://dx.doi.org/10.1182/blood-2003-03-0877>10.1182/blood-2003-03-0877</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR10_16</td><td>BibArticle</td><td>Aldouri MA, Ruggier R, Epstein O, Prentice HG. (1990). Adoptive transfer of hyperthyroidism and autoimmune thyroiditis following allogeneic bone marrow transplantation for chronic myeloid leukaemia. Br J Haematol; 74(1):118&#8211;119.</td><td><a href=http://dx.doi.org/10.1111/j.1365-2141.1990.tb02548.x>10.1111/j.1365-2141.1990.tb02548.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR11_16</td><td>BibArticle</td><td>Wyatt DT, Lum LG, Casper J, Hunter J, Camitta B. (1990). Autoimmune thyroiditis after bone marrow transplantation. Bone Marrow Transplant; 5(5):357&#8211;361.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR12_16</td><td>BibArticle</td><td>Fassas A, Anagnostopoulos A, Kazis A, Kapinas K, Sakellari I, Kimiskidis V, Smias C, Eleftheriadis N, Tsimourtou V. (2000). Autologous stem cell transplantation in progressive multiple sclerosis &#8211; an interim analysis of efficacy. J Clin Immunol; 20(1):24&#8211;30.</td><td><a href=http://dx.doi.org/10.1023/A:1006686426090>10.1023/A:1006686426090</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR13_16</td><td>BibArticle</td><td>Weinshenker BG. (1994). Natural history of multiple sclerosis. Ann Neurol; 36:6&#8211;11.</td><td><a href=http://dx.doi.org/10.1002/ana.410360704>10.1002/ana.410360704</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR14_16</td><td>BibArticle</td><td>Adami GF, Bacigalupo A, Bonalumi U, Van Lindt MT, Griffanti-Bartoli F. (1981). Use of Hickman right atrial catheter for vascular access in marrow transplant recipients. Arch Surg; 116(8):1099.</td><td><a href=http://dx.doi.org/10.1001/archsurg.1981.01380200095023>10.1001/archsurg.1981.01380200095023</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR15_16</td><td>BibArticle</td><td>Hickman RO, Buckner CD, Clift RA, Sanders JE, Stewart P, Thomas ED. (1979). A modified right atrial catheter for access to the venous system in marrow transplant recipients. Surg Gynecol Obstet; 148(6):871&#8211;875.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR16_16</td><td>BibArticle</td><td>Sutherland DR, Anderson L, Keeney M, Nayar R, Chin-Yee I. (1996). The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering. J Hematother; 5(3):213&#8211;226.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR17_16</td><td>BibUnstructured</td><td><span style='background:#FF3300'>http://www.halls.md/body-surface-area/bsa.htm</span>.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR18_16</td><td>BibArticle</td><td>Mitterer M, Hirber J, Gentilini I, Prinoth O, Fabris P, Emmerich B, Coser P, Straka C. (1996). Target value tailored (TVT) apheresis approach for blood progenitor cell collection after high-dose chemotherapy and rh-G-CSF. Bone Marrow Transplant; 18(3):611&#8211;617.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR19_16</td><td>BibArticle</td><td>Copelan EA. (2006). Hematopoietic stem-cell transplantation. N Engl J Med27; 354(17):1813&#8211;1826.</td><td><a href=http://dx.doi.org/10.1056/NEJMra052638>10.1056/NEJMra052638</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR20_16</td><td>BibArticle</td><td>Leger CS, Nevill TJ. (2004). Hematopoietic stem cell transplantation: a primer for the primary care physician. Can Med Assoc J; 170(10):1569&#8211;1577.</td><td><a href=http://dx.doi.org/10.1503/cmaj.1011625>10.1503/cmaj.1011625</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR21_16</td><td>BibArticle</td><td>Dix SP, Wingard JR, Mullins RE, Jerkunica I, Davidson TG, Gilmore CE, et al. (1996). Association of busulfan area under the curve with veno-occlusive disease following BMT. Bone Marrow Transplant; 17:225&#8211;230.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR22_16</td><td>BibArticle</td><td>Lowance D, Neumayer HH, Legendre CM, Squifflet JP, Kovarik J, Brennan PJ, et al. (1999). Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group. N Engl J Med; 340:1462&#8211;1470.</td><td><a href=http://dx.doi.org/10.1056/NEJM199905133401903>10.1056/NEJM199905133401903</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>Author_FamilyName_2, Author_FamilyName_1, Year, FirstPage, ArticleTitle, VolumeID</td><td>CrossRef</td></tr><tr><td>CR23_16</td><td>BibArticle</td><td>Feinberg JE, Hurwitz S, Cooper D, Sattler FR, MacGregor RR, Powderly W, et al. (1998). A randomized, double-blind trial of valaciclovir prophylaxis for cytomegalovirus disease in patients with advanced human immunodeficiency virus infection. AIDS Clinical Trials Group Protocol 204/Glaxo Wellcome 123&#8211;014 International CMV Prophylaxis Study Group. J Infect Dis; 177:48&#8211;56.</td><td>&nbsp;</td><td><a href=http://dx.doi.org/10.1086/513804>10.1086/513804</a></td><td><b>CrossRef-Meta</b></td>
<td>VolumeID, Author_FamilyName_1, Author_FamilyName_2, Year, FirstPage</td><td>CrossRef</td></tr><tr><td>CR24_16</td><td>BibArticle</td><td>McDiarmid S, Hamelin L, Huebsch LB. (2006). Leading change: Retrospective evaluation of a nurse-led initiative in vascular access options for autologous stem cell transplant recipients ranging from Hickman catheters to peripherally inserted central catheters. J Infus Nurs; 29(2):81&#8211;88.</td><td><a href=http://dx.doi.org/10.1097/00129804-200603000-00005>10.1097/00129804-200603000-00005</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr></table>